Hap Trading, LLC Tricida, Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.14 - $12.49 $434 - $38,719	-3,100 Reduced 22.3%	10,800 $0
Q3 2022 Nov 14, 2022	SELL	$8.51 - $13.6 $1,702 - $2,720	-200 Reduced 1.42%	13,900 $72,000
Q2 2022 Aug 12, 2022	SELL	$7.31 - $11.85 $9,503 - $15,405	-1,300 Reduced 8.44%	14,100 $55,000
Q1 2022 May 12, 2022	SELL	$7.35 - $10.63 $49,980 - $72,284	-6,800 Reduced 30.63%	15,400 $51,000
Q4 2021 Feb 14, 2022	BUY	$4.19 - $9.56 $93,018 - $212,232	22,200 New	22,200 $47,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.